Childhood & Maternal Vaccines
Vaccination is the best technique for forestalling irresistible diseases; far reaching invulnerability because of inoculation is to a great extent in charge of the overall annihilation of smallpox and the disposal of illnesses, for example, polio, measles, and lockjaw from a great part of the world. Maternal inoculation is a viable technique to forestall as well as limit the seriousness of irresistible illnesses in pregnant ladies and their newborn children
Related Conference of Childhood & Maternal Vaccines
March 24-25, 2027
10th International Conference on Vaccines, Immunology and Clinical Trials
Paris, France
July 27-28, 2027
8th International conference on Vaccines, Vaccination and Immunization
Paris, France
Childhood & Maternal Vaccines Conference Speakers
Recommended Sessions
- Animal Vaccination
- Antibodies: Engineering & Therapeutics
- Bacterial Vaccines
- Cancer Vaccines & Immunotherapy
- Childhood & Maternal Vaccines
- COVID-19 Vaccine Research & Development
- DNA Based Vaccines
- Geriatric Immunization
- HIV/AIDS Vaccines
- HPV & Hepatitis Vaccines
- Human Vaccines-Infectious & Non-Infectious
- Immunizations & Bioterrorism
- Modern Technologies In Vaccine Discovery & Development
- Mosquito-Borne Diseases-Vaccines
- Plant Derived Vaccines
- Protein Based Vaccines
- Toxoid Vaccines
- Travel Immunization
- Vaccine Industry
- Vaccine Safety & Efficacy
- Vaccines & Immunizations
- Vaccines for Immune Mediated Diseases
- Vaccines for Pregnant Women & Neonates
- Vaccines Preclinical & Clinical Trials
- Viral Vaccines
Related Journals
Are you interested in
- Adaptive Immunity and Immune Regulation - Vaccines R&D 2027 (France)
- Adult and Healthy Aging Vaccination - Vaccines-Immunization-2027 (France)
- Advanced Vaccine Research and Innovation - VACCINE CONGRESS 2026 (Japan)
- Advances in Vaccine Research and Development - Vaccines-Immunization-2027 (France)
- Allergy and Clinical Immunology - Vaccines R&D 2027 (France)
- Artificial Intelligence in Vaccine Discovery - Vaccines R&D 2027 (France)
- Artificial Intelligence in Vaccine Research - VACCINE CONGRESS 2026 (Japan)
- Artificial Intelligence, Digital Health and Vaccine Innovation - Vaccines-Immunization-2027 (France)
- Autoimmunity and Immune Disorders - Vaccines R&D 2027 (France)
- Bioinformatics and AI in Vaccine Design - Vaccine Immunology 2027 (France)
- Bioinformatics and Computational Immunology - Vaccines R&D 2027 (France)
- Biomarkers in Immunology and Clinical Research - Vaccines R&D 2027 (France)
- Biostatistics and Epidemiology in Vaccine Research - VACCINE CONGRESS 2026 (Japan)
- Biotechnology and Vaccine Engineering - VACCINE CONGRESS 2026 (Japan)
- Cancer Vaccines and Immunotherapy - Vaccines R&D 2027 (France)
- Challenges in Vaccine Accessibility and Equity - Vaccine Immunology 2027 (France)
- Childhood Vaccination and Routine Immunization - Vaccines-Immunization-2027 (France)
- Clinical Trial Design and Regulatory Affairs - Vaccines R&D 2027 (France)
- Clinical Trials and Vaccine Evaluation - VACCINE CONGRESS 2026 (Japan)
- Clinical Trials in Vaccinology - Vaccines R&D 2027 (France)
- Clinical Vaccinology and Immunization Practice - VACCINE CONGRESS 2026 (Japan)
- Clinical Vaccinology and Immunotherapy - Vaccine Immunology 2027 (France)
- Cold Chain, Storage and Vaccine Delivery Systems - Vaccines-Immunization-2027 (France)
- Digital Health in Clinical Trials - Vaccines R&D 2027 (France)
- Emerging & Re-emerging Infectious Diseases - Vaccines R&D 2027 (France)
- Emerging and Neglected Disease Vaccines - Vaccines-Immunization-2027 (France)
- Emerging Infectious Diseases - Vaccine Immunology 2027 (France)
- Emerging Trends in Vaccine Science - VACCINE CONGRESS 2026 (Japan)
- Ethical, Legal and Regulatory Aspects of Clinical Research - Vaccines R&D 2027 (France)
- Future Directions in Vaccine Research - Vaccine Immunology 2027 (France)
- Future of Vaccines and Pandemic Preparedness - Vaccines-Immunization-2027 (France)
- Global Health and Vaccine Equity - VACCINE CONGRESS 2026 (Japan)
- Global Immunization Programmes and Public Health - Vaccines-Immunization-2027 (France)
- Global Vaccination Programs and Public Health - Vaccines R&D 2027 (France)
- Global Vaccination Strategies - Vaccine Immunology 2027 (France)
- HPV Vaccination and Cancer Prevention - Vaccines-Immunization-2027 (France)
- Human Microbiome and Vaccines - Vaccine Immunology 2027 (France)
- Immunogenetics and Genomic Medicine - Vaccines R&D 2027 (France)
- Immunogenetics and Personalized Vaccines - Vaccine Immunology 2027 (France)
- Immunogenetics and Personalized Vaccines - Vaccine Immunology 2027 (France)
- Immunology and Host Immune Response - VACCINE CONGRESS 2026 (Japan)
- Immunology and Immune System Innovations - Vaccine Immunology 2027 (France)
- Immunology and Immune System Mechanisms - Vaccines R&D 2027 (France)
- Immunology of Infectious Diseases - Vaccine Immunology 2027 (France)
- Immunotherapy and Vaccines for Non-Infectious Diseases - Vaccine Immunology 2027 (France)
- Immunotherapy in Cancer Treatment - Vaccine Immunology 2027 (France)
- Industrial Vaccine Manufacturing and Scale Up - VACCINE CONGRESS 2026 (Japan)
- Industry and Technology Innovations - Vaccine Immunology 2027 (France)
- Infectious Diseases and Immunization Strategies - Vaccines R&D 2027 (France)
- Influenza, RSV and Respiratory Virus Vaccines - Vaccines-Immunization-2027 (France)
- Innovations in Vaccines, Immunology and Clinical Trials - Vaccines R&D 2027 (France)
- Maternal, Neonatal and Adolescent Immunization - Vaccines-Immunization-2027 (France)
- Maternal, Neonatal, and Geriatric Immunization - Vaccine Immunology 2027 (France)
- Microbiome-Targeted Vaccines - Vaccine Immunology 2027 (France)
- Monoclonal Antibodies and Biologics - Vaccines R&D 2027 (France)
- mRNA and Nucleic Acid Vaccines - Vaccines-Immunization-2027 (France)
- mRNA, DNA & Viral Vector Vaccines - Vaccines R&D 2027 (France)
- Mucosal and Innate Immunity - Vaccines R&D 2027 (France)
- Nanotechnology and Advanced Delivery Systems - Vaccine Immunology 2027 (France)
- Nanotechnology in Vaccine Delivery - VACCINE CONGRESS 2026 (Japan)
- Nanotechnology in Vaccine Delivery - Vaccine Immunology 2027 (France)
- Next Generation Vaccines and Emerging Technologies - VACCINE CONGRESS 2026 (Japan)
- Next-Generation Vaccine Platforms - Vaccine Immunology 2027 (France)
- Next-Generation Vaccine Technologies - Vaccines-Immunization-2027 (France)
- Next-Generation Vaccine Technologies - Vaccines R&D 2027 (France)
- Novel Vaccine Platforms: mRNA, DNA, and Viral Vectors - Vaccine Immunology 2027 (France)
- One Health Approach to Vaccine Development - Vaccine Immunology 2027 (France)
- Pandemic Preparedness and Response - Vaccine Immunology 2027 (France)
- Pandemic Preparedness and Vaccine Development - Vaccines R&D 2027 (France)
- Pediatric and Adult Immunization - Vaccines R&D 2027 (France)
- Personalized Vaccinology and Precision Immunization - VACCINE CONGRESS 2026 (Japan)
- Precision Immunology and Personalized Vaccines - Vaccines R&D 2027 (France)
- Public Health and Global Immunization - Vaccine Immunology 2027 (France)
- Public Health and Immunization Policy - VACCINE CONGRESS 2026 (Japan)
- Regulatory Affairs and Vaccine Approval Systems - VACCINE CONGRESS 2026 (Japan)
- Regulatory Affairs and Vaccine Policy - Vaccines-Immunization-2027 (France)
- The Economics of Vaccination - Vaccine Immunology 2027 (France)
- Therapeutic Vaccines - Vaccines R&D 2027 (France)
- Translational Immunology - Vaccines R&D 2027 (France)
- Vaccine Adjuvants and Delivery Systems - Vaccines R&D 2027 (France)
- Vaccine Clinical Trials and Evaluation - Vaccines-Immunization-2027 (France)
- Vaccine Delivery Systems and Formulations - VACCINE CONGRESS 2026 (Japan)
- Vaccine Design and Molecular Biology - VACCINE CONGRESS 2026 (Japan)
- Vaccine Discovery and Development - VACCINE CONGRESS 2026 (Japan)
- Vaccine Equity, Access and Global Health - Vaccines-Immunization-2027 (France)
- Vaccine Hesitancy and Public Trust - Vaccine Immunology 2027 (France)
- Vaccine Hesitancy, Confidence and Public Communication - Vaccines-Immunization-2027 (France)
- Vaccine Immunology and Immune Responses - Vaccines-Immunization-2027 (France)
- Vaccine Manufacturing and Quality Control - Vaccines R&D 2027 (France)
- Vaccine Manufacturing, Quality Control and Scale-Up - Vaccines-Immunization-2027 (France)
- Vaccine Production and Global Supply Chains - Vaccine Immunology 2027 (France)
- Vaccine Research and Development - Vaccine Immunology 2027 (France)
- Vaccine Research and Development - Vaccines R&D 2027 (France)
- Vaccine Safety and Adverse Event Monitoring - Vaccine Immunology 2027 (France)
- Vaccine Safety and Pharmacovigilance - VACCINE CONGRESS 2026 (Japan)
- Vaccine Safety, Efficacy & Pharmacovigilance - Vaccines R&D 2027 (France)
- Vaccine Safety, Pharmacovigilance and Adverse Events - Vaccines-Immunization-2027 (France)
- Vaccine Safety, Pharmacovigilance, and Adverse Event Monitoring - Vaccine Immunology 2027 (France)
- Vaccine-Induced Immunity and Duration of Protection - Vaccine Immunology 2027 (France)
- Viral and Bacterial Vaccine Research - VACCINE CONGRESS 2026 (Japan)